A Prospective, Double-blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of Mupirocin Cream USP 2% (Supplied by: Glasshouse Pharmaceuticals Limited Canada) using Mupirocin Cream USP 2% (Manufactured by: Glenmark Pharmaceuticals Inc; USA) as a Reference Product, in Subjects with Secondarily Infected Traumatic Skin Lesion
A Multi- Centre, randomized, open label, multiple dose, two treatment, two-way steady state cross over, bioequivalence study comparing Felbamate oral suspension 600mg/5 mL of Glasshouse Pharmaceutical Limited Canada to the Reference Listed Drug(RLD), Felbatol (Felbamate) oral suspension 600mg/5mL in adult male and non-pregnant female epilepsy patients under fasting condition.
A Randomized, Open label, Multicentric, Parallel-group, Three Arm Clinical Study to Compare the Efficacy and Safety of Test formulations of Permethrin 5% of Glasshouse Pharmaceuticals Limited Canada versus Elimite® (Permethrin) 5% Cream of Prestium Pharma, Inc. in adult Subjects with Scabie - NA
100 项与 Glasshouse Pharmaceuticals Ltd. 相关的临床结果
0 项与 Glasshouse Pharmaceuticals Ltd. 相关的专利（医药）
100 项与 Glasshouse Pharmaceuticals Ltd. 相关的药物交易
100 项与 Glasshouse Pharmaceuticals Ltd. 相关的转化医学
